Aaron Pinion, DO
Allergy & Immunology · Elk River, MNNPI 1255642294
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,957 of the $4,367 with a category attached, or 67.7%. 21 manufacturers reported payments, led by Genentech USA, Inc. at 28.2% of the total. 2025 is the largest year on record at $1,595, more than ten times the $114 reported in 2021.
Across 135 payments — averaging $32.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$1K
- Sanofi$893
- AstraZeneca$844
- Sanofi-aventis U.S. LLC$195
- CSL Behring$194
- Amgen$180
- plus $831 from 15 others
What the payments were for
- Consulting fees$1,21528%
- Food & beverage$2,95768%
- Education$1954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 2 | $1,231 |
| Sanofi | 54 | $893 |
| AstraZeneca | 16 | $844 |
| Sanofi-aventis U.S. LLC | 2 | $195 |
| CSL Behring | 8 | $194 |
| Amgen(2 entities) | 10 | $180 |
| Lilly USA, LLC | 8 | $126 |
| AbbVie | 5 | $119 |
| Novartis | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Kerecis Limited | 2 | $71 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Ionis Pharmaceuticals, Inc. | 3 | $54 |
| Pfizer | 2 | $36 |
| Pharming Healthcare, Inc. | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,367 in reported general payments places this provider in the 75th percentile of 57 allergy & immunology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $99,744 |
| TezspireTezepelumab-Ekko | 17 | $75,282 |
| Dupixent PenDupilumab | 16 | $74,729 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 109 | $70,276 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 11 | $44,525 |
| XolairOmalizumab | 17 | $44,467 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $8,265 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $7,309 |
| Spiriva RespimatTiotropium Bromide | 14 | $7,101 |
| Azelastine Hcl | 131 | $4,958 |
| Epinephrine | 14 | $3,524 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $3,073 |
| Ipratropium Bromide | 71 | $2,513 |
| Mometasone Furoate | 18 | $1,744 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $194 | $99,74411 claims |
| AstraZenecaTezspire, Symbicort | $844 | $83,54748 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 57 allergy & immunology providers in Minnesota.
Other allergy & immunology in Elk River
- Nicole ChaseSaint Paul$1.8M
- Jason RaaschPlymouth$153K
- Thanai PongdeeRochester$58K
- Elina JerschowRochester$45K
- Nancy OttMinneapolis$23K
- David LoweRochester$18K
- Srinivasan RamanujaMankato$18K
- Douglas McMahonMaplewood$18K
- Niladri AichbhaumikSaint Paul$15K
- Dayne VoelkerRochester$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.